Tango Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview

Tango Therapeutics

04/08/2023 19:35

* Tango Therapeutics Inc  TNGX.OQ   TNGX.O  is expected
to show a
rise in quarterly revenue when it reports  results on August 8
(estimated). 
    * The Boston Massachusetts-based  company is expected to
report  a
20.4% increase in revenue to $6.95 million from $5.77 million a
year ago, according to the mean estimate from 5 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Tango Therapeutics
Inc is
for a loss of 34 cents per share. 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Tango
Therapeutics Inc is $16​, above​ its last closing price
of $3.39. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.35       -0.35      -0.32     Beat    8.9
 Dec. 31 2023              -0.35      -0.33     Beat    7
 Sep. 30 2022  -0.32       -0.32      -0.33     Missed  -2.1​
 Jun. 30 2022  -0.32       -0.32      -0.28     Beat    13.6
 ​​Mar.        -0.28       -0.28      -0.29     Missed  -4.3
 31 2022                                                
 Dec. 31 2021              -0.27      -0.25     Beat    7.4​
 Sep. 30 2021  -0.28       -0.28      -0.28     Met     0.7
 This summary was machine generated August 4 at 18:34 GMT.  All
figures in US dollars  unless otherwise stated